The 34 th Meeting of the Scandinavian Sarcoma Group 30 Years Jubilee
|
|
|
- Miles Payne
- 7 years ago
- Views:
Transcription
1 PROGRAM The 34 th Meeting of the Scandinavian Sarcoma Group 30 Years Jubilee Date: May 6 8, 2009 Oslo Scandinavian Sarcoma Group 1979 Place: Hotel Opera Christian Frederiksplass Oslo Tel: Fax: Symposium Wednesday May 6, 2009 The Biology of Mesenchymal Tumors Place: RH Rikshospitalet, Sognsvannsveien 20 Room: RH B2. U002 (Seminarrom 2) 8:00 8:45 The Pathology of Sarcoma 8:45 9:30 The Sarcoma Progenitor Cell. I. Stamenkovic, Institute of Pathology, University of Lausanne 9:30 10:15 Cancer Stem cells and Mesenchymal tumors O. Myklebost Rikshospitalet-Radiumhospitalet Med. Center, Oslo 10:15 10:30 Coffe break 10:30 11:15 Cytogenetic patterns and fusion genes in bone and ST tumors. F. Mertens, Clinical Genetics, Lund University Hospital 11:15 12:00 Functional analysis of a FET family fusion oncogene. P. Åman. Lundberg Laboratory for Cancer Research, Göteborg 12:00 13:00 Lunch 13:00 13:45 Is p53 involved in sarcoma development? B. Brodin, Dpt of Oncology and Pathology, Karolinska Institutet 13:45 14:30 Receptor Tyrosine kinases and cell signalling pathways in Sarcoma. K. Scotlandi. Inst Ortopedici Rizzoli, Bologna Italy 14:30 14:45 Coffe break 14:45 15:30 New therapeutical approaches in sarcoma treatment. P. Picci, Inst Ortopedicci Rizzoli, Bologna Italy 15:30 16:15 Integrated analysis mining biomarkers of Sarcoma: copy numbers mrna and micrornas expression. S. Knuutila, Haartman Institute, University of Helsinki 16:15 17:00 Inflammation and sarcomas. J. Vakkila, Haartman Institute, University of Helsinki 2
2 Program for SSG 30 years jubilee Wednesday May 6, Registration Place: outside the conference room Flagstadsalen Poster exhibition Place: inside the conference room Flagstadsalen SSG Central register meeting Room: Figaro SSG Board meeting Room: Figaro Introduction and welcome Room: Flagstadsalen K. Sundby Hall, Oslo, H. Bauer, Stockholm, T.A. Alvegård, Lund L1 Minisymposium: The role of trabectedin in the treatment of soft tissue sarcoma. J-Y. Blay, Lyon, France Dinner and cultural event at Opera Hotel (Restaurant: Scala) Thursday May 7, Breakfast Registration Place: Outside the conference room Flagstadsalen L2 The role of conventional and functional imaging in sarcoma D. Vanel, Bologna, Italy Discussion Session I Bone sarcoma Chairmen: S. Smeland, Oslo, L. Hjorth, Lund, O. Brosjö, Stockholm L3 Treatment of Ewing s sarcoma: current standard and future aspects H. Jürgens, Münster, Germany Discussion L4 Chondromatous tumors-from benign entity to highly malignant chondrosarcomas. P.C.W. Hogendoorn, Leyden, Netherland Discussion L5 Osteosarcoma. Multidisciplinary management: The pathologist s perspective A.K. Raymond, N.X. Chen, Houston, Texas Discussion L6 Demographic study of 1500 osteosarcoma patients P. Picci, Bologna, Italy Discussion L7 SSG`s experiences in osteosarcoma and Ewing sarcoma S. Smeland, Oslo Discussion Coffee break 3 4
3 Free presentations L8 Characteristics of patients in a US postmarketing osteosarcoma surveillance study A. Gilsenan, et.al., RTP, NC, USA L9 Histology of the physis following an extensible endoprosthesis in children with a malignant primary bone tumour around the knee W.P. Cool, et.al., United Kingdom L10 Resection of the spine for primary tumors. Principles and technique. B. Gunterberg, et.al., Gothenburg L11 EURAMOS-1: A randomized European/American osteosarcoma study S. Smeland, et.al., Oslo Lunch Session II Soft tissue sarcoma Chairmen: K. Sundby Hall, Oslo, J. Engellau, Lund Presentations of SSG theses: concluded and ongoing L12 Prognostic systems for soft tissue sarcoma of the extremities and trunk wall in adults J. Engellau, Lund L13 Clinical and molecular studies of liposarcoma K. Engström, Gothenburg L14 Soft tissue leiomyosarcoma A summary of the SSG project K. Svarvar, et.al., Helsinki L15 Radiotherapy in soft tissue sarcoma. An SSG thesis project N. Jebsen, et.al., Bergen L16 Chest wall chondrosarcoma B. Widhe, H. Bauer, Stockholm L17 New techniques in radiotherapy of sarcomas R. Schwarz, Hamburg, Germany Discussion L18 The role of chemotherapy in soft tissue sarcoma S. Patel, Houston, USA Discussion L19 SSG experiences in soft tissue sarcomas K. Sundby Hall, et.al., Oslo Discussion Coffee break Free presentations Chairmen: H. Bauer, Stockholm, P. Lindholm, Turku L20 The prognosis of radiation-induced sarcoma compared to sporadic sarcoma B. Bjerkehagen, et.al., Oslo L21 Imaging of glucose metabolism and perfusion in musculoskeletal tumours by positron emission tomography (PET) P. Lindholm, et.al., Turku L22 New prognostic markers for malignant peripheral nerve sheath tumors M. Kolberg, et.al., Oslo Light dinner at Opera hotel (Restaurant: Scala) Opera Carmen 6
4 Friday, May 8, Breakfast Session III Visceral and retroperitoneal sarcoma Chairmen: J. Åhlén, Stockholm, M. Eriksson, Lund L23 Recommendations for the diagnosis and treatment of intraabdominal, pelvic, retroperitoneal and uterine sarcomas J. Åhlén, Stockholm L24 GIST: From palliative to adjuvant treatment H. Joensuu, Helsinki Discussion Free presentations L25 Large intestinal GIST with high-risk criteria in a neonate treated with surgery only Å. Jacobson, et.al., Stockholm L26 The effects of hyperthermia on the concentration of soluble TNFreceptor 1 in isolated limb perfusion L. E. Podleska, et.al., Essen, Germany L27 Delayed methotraxate elimination: may fruit drinks have a clinical impact? K Sundby Hall, et.al., Oslo L28 Targeting the P53/HDM2 interaction as a therapeutic strategy in synovial sarcoma P. Darcy, et.al., Stockholm L29 Novel druggable targets identified in gene expression profiles of MPNSTs and neurofibromas T. H. Ågesen, et.al., Oslo Coffee break Poster session Chairmen: Ø.S. Bruland, Oslo, H. Bauer, Stockholm, T. Böhling, Helsinki Lunch Session IV Joint session with nurses and physiotherapists Chairmen: H. Bauer, Stockholm, K. Sundby Hall, Oslo L30 Late events in osteosarcoma survivors: What can we learn from clinical trials in amputation versus limb salvage? G. Ottaviani, et.al., Milan, Italy L31 Health status in bone sarcoma survivors L.H. Aksnes, et.al., Oslo Discussion L32 High-dose Methotrexate has the time come for common procedures? L. Våde, I. Nordhagen, Oslo L33 Transcultural caring relationships P. Pergert, Stockholm L34 Healt-related Quality of Life, school and social interaction with friends during childhood cancer treatment M. af Sandeberg, Stockholm Coffee break SSG Matters Conclusions 7 8
5 Program for SSG nurses and physiotherapists Wednesday, May 6, Registration Place: Outside the conference room Flagstadsalen Poster exhibition Place: inside the conference room Flagstadsalen Introduction and welcome Room: Flagstadsalen K. Sundby Hall, Oslo, H. Bauer, Stockholm, T.A. Alvegård, Lund Minisymposium: The role of trabectedin in the treatment of soft tissue sarcoma. J-Y. Blay, Lyon, France Dinner and cultural event at Opera Hotel (Restaurant: Scala) Thursday, May 7, Breakfast Velkommen S. Granlien, Oslo Nurses and physiotherapists session Place: Storkvinten Chairmen: L. Våde, Oslo, S. Granlien, Oslo L35 Tanker om den vanskelige samtalen S. Rian, S. Granlien, Oslo L36 Veien tilbake til livet og hverdagen etter sarkombehandling S. Lindberg, K. Bach Fossdal, Stavern L37 Hvorfor skal jeg bare ligge på sengen? T. Kollenborg, Oslo L38 Sygepleje til unge sådan plejer vi den unge patient i Århus, Danmark N. Hove, Århus L39 Oro och nedstämdhet hos personer som behandlats för osteo- eller Ewingsarkom H. Lernedal, Stockholm L40 Aloxi (Palonosetron) en ny seratoninantagonist B. Augdal, Göteborg Coffee break L41 Ernæring, et felles ansvar! K. Mac Quarrie, A. Bøe, Oslo L42 Illamående i cancervården- ett antiemetika projekt på Radiumhemmet i Stockholm K. Wieselblad, L. Smedberg, Stockholm L43 PhaSeal - sluten hantering av toxiska läkemedel C. Hallberg, Göteborg Lunch 9 10
6 12.50 L44 Sårbehandling til patienter, der har fået fjernet et sarkom B. Hedegård, A. Sophie Koch, Århus L45 Knokkel-rekonstruksjoner etter sarkomkirurgi O-J. Norum, Oslo L46 Fysioterapi ved rekonstruksjoner H. Blegen, G.S. J. Haugen, M.L. Johansen, Oslo L47 Genoptræning af overekstremiteter med og uden anvendelse at protese ved patienter med sarkom E. Rasmussen, H. Brandt Andersen, København L48 Prinsipper for og eksempler på balansetrening Ls-A. Andersen, Bergen Coffee break Årsmöte Dinner at Opera hotel (Restaurant: Scala) Opera Carmen 11 Friday, May 8, Breakfast Avreise fra Hotell Opera till Radiumhospitalet Møtesplass: Christion Fredriks plass Omvisning på Kreftklinikken, Radiumhospitalet L49 Presentasjon av Sarkomforum for sykepleie og fysioterapi på Radiumhospitalet L50 Primærsykepleie til sarkompasienter, hvorfor? J. Marstein, Oslo L51 En pasients historie Lunch (Hotel Opera) Session IV Joint session with nurses and physiotherapists Chairmen: H. Bauer, Stockholm, K. Sundby Hall, Oslo Room: Flagstadsalen Late events in osteosarcoma survivors: What can we learn from clinical trials in amputation versus limb salvage? G. Ottaviani, Milan, Italy SSG study: Health status in bone sarcoma survivors L.H. Aksnes, Oslo Discussion MTX time for common routines? I. Nordhagen, L. Våde Norwegian Radium Hospital, Oslo Transcultural caring relationships P. Pergert Astrid Lindgren Children s Hospital, Stockholm Healt related Quality of Life, school and social interaction with friends during childhood cancer treatment M. af Sandeberg, Stockholm Coffee break SSG Matters Conclusions 12
FINAL PROGRAM. The 36 th Meeting of the Scandinavian Sarcoma Group
FINAL PROGRAM The 36 th Meeting of the Scandinavian Sarcoma Group Helsinki Date: October 9-11, 2013 Place: Hotel Crowne Plaza Mannerheimentie 50 Helsinki 00260 Finland Hotel Front Desk +358-9-2521 0000
The 33 rd Meeting of the Scandinavian Sarcoma Group
The 33 rd Meeting of the Scandinavian Sarcoma Group Bergen Radisson SAS Royal Hotel May 8 11, 2007 Program Contents Preface...3... Tuesday May 8, 2007...4 Wednesday May 9, 2007...5 6 Thursday May 10, 2007...9
ADJUVANT TREATMENT CLINICAL EVALUATION NEOADJUVANT TREATMENT
te: Consider Clinical Trials as treatment options for eligible patients. Referral to a center with both pediatric oncology and orthopedic surgery is essential. CLINICAL EVALUATION This practice algorithm
Soft tissue sarcoma. 329 Soft tissue sarcoma Page 1 of 11
Soft tissue sarcoma Page 1 of 11 Introduction This booklet is to give you, your family and your friends some information about this group of illnesses, and how we treat them at The Christie. Introduction:
1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1
1 page Overview 21 Oct Tuesday 1500 on REGISTRATION 1800 Welcome Reception & Cocktails at the Cape Town International Conference Centre (CTICC) 22 Oct Wednesday 0730 REGISTRATION 0830 OPENING 0900 PLENARY
The evolving pathology of solitary fibrous tumours. Luciane Dreher Irion MREH / CMFT / NSOPS
The evolving pathology of solitary fibrous tumours Luciane Dreher Irion MREH / CMFT / NSOPS Historical review Haemangiopericytoma (HPC) first described primarily as a soft tissue vascular tumour of pericytic
Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle
Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle TITLE PROJET NOM HOPITAL Assessment of tumor angiogenesis using PET/CT with 18 F-Galacto- RGD. (PNC_29_001) Division of
INTERNATIONAL COURSE:
INTERNATIONAL COURSE: Novel mechanisms of signal transduction involved in cancer chemoresistance - Focus on IGF signaling integration and cross-talk. University Campus S Venuta - Catanzaro, Italy Lecture
MUSCULOSKELETAL ONCOLOGY COURSE
MUSCULOSKELETAL ONCOLOGY COURSE A Course of University of Padova Department of Orthopedics and Orthopedic Oncology September 16 18, 2016 MESTRE (Venezia, Italy) This is the first edition of the Musculoskeletal
Immunohistochemistry of soft tissue tumors
Immunohistochemistry of soft tissue tumors Immunohistochemistry Major advances : antigen retrieval techniques (HIER) sensitive detection systems numerous antibodies of good quality Standardization : automated
EFORT Spring Travelling Fellowship
Welcome to! Dear Fellow, The EFORT Courses are organised by the National Orthopaedic Societies, member of the European Federation of National Associations of Orthopaedics and Traumatology. The EFORT of
Advances in Biology and Treatment of Malignant Brain Gliomas
Advances in Biology and Treatment of Malignant Brain Gliomas International Congress 2 nd Edition Rome, June 12-13, 2014 President Giulio Maira Vice Presidents Ruggero De Maria, Antonio Iavarone, Angelo
CancerStemCell Markers in Lung Cancers: Proofsof. Reservations. Lourdes Cortes-Dericks, PhD University of Hamburg Hamburg, Germany
CancerStemCell Markers in Lung Cancers: Proofsof ConceptsandSome Reservations Lourdes Cortes-Dericks, PhD University of Hamburg Hamburg, Germany Lung cancer: highest death rate and poorest patient survival
2 nd ESSO Advanced Course on the Surgical and Medical Management of Melanoma
2 nd ESSO Advanced Course on the Surgical and Medical Management of Melanoma Focus on stage III and IV melanoma In partnership with the Society of Surgical Oncology (SSO) 12-14 November 2015 ATHENS (GR)
EUGMS 2015. OSLO 16-19 september Norway ( den 6 norske kongressen i geriatri 15 september)
EUGMS 2015 OSLO 16-19 september Norway ( den 6 norske kongressen i geriatri 15 september) Presentasjon under styremøtet Full board EUGMS 6 mars 2013 Geriatric medicine for future Eoropeans Successfull
Cancerfondens planeringsgrupp för Onkologisk Nuklidterapi meeting 2015 25-27 November 2015
Cancerfondens planeringsgrupp för Onkologisk Nuklidterapi meeting 2015 25-27 November 2015 Place: Lecture Hall EKEN, Entrance 65, CAMPUS US, The Faculty of Medicine and Health Science, Linköping University,
A practical guide to understanding cancer
A practical guide to understanding cancer Contents Contents About this booklet 4 What is cancer? 5 The lymphatic system 7 Soft tissue sarcomas 8 Types of soft tissue sarcoma 10 Risk factors and causes
Clinical Commissioning Policy: Proton Beam Radiotherapy (High Energy) for Paediatric Cancer Treatment
Clinical Commissioning Policy: Proton Beam Radiotherapy (High Energy) for Paediatric Cancer Treatment Reference: NHS England xxx/x/x 1 Clinical Commissioning Policy: Proton Beam Radiotherapy (High Energy)
Detection and staging of recurrent prostate cancer is still one of the important clinical problems in prostate cancer. A rise in PSA or biochemical
Summary. 111 Detection and staging of recurrent prostate cancer is still one of the important clinical problems in prostate cancer. A rise in PSA or biochemical recurrence (BCR) is the first sign of recurrent
Houston Cancer Institute
Houston Cancer Institute A personal path to healing Memorial-West Houston Katy Northwest Houston Southeast Houston Sugar Land Convenience for Patients State of the Art Therapies and Diagnosis Real Support
Prostate Cancer. Treatments as unique as you are
Prostate Cancer Treatments as unique as you are UCLA Prostate Cancer Program Prostate cancer is the second most common cancer among men. The UCLA Prostate Cancer Program brings together the elements essential
Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma
Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma Medical Expert: Breast Rotation Specific Competencies/Objectives 1.0 Medical History
Lung cancer is not just one disease. There are two main types of lung cancer:
1. What is lung cancer? 2. How common is lung cancer? 3. What are the risk factors for lung cancer? 4. What are the signs and symptoms of lung cancer? 5. How is lung cancer diagnosed? 6. What are the available
Mesothelioma. 1. Introduction. 1.1 General Information and Aetiology
Mesothelioma 1. Introduction 1.1 General Information and Aetiology Mesotheliomas are tumours that arise from the mesothelial cells of the pleura, peritoneum, pericardium or tunica vaginalis [1]. Most are
The Diagnosis of Cancer in the Pathology Laboratory
The Diagnosis of Cancer in the Pathology Laboratory Dr Edward Sheffield Christmas Select 74 Meeting, Queen s Hotel Cheltenham, 3 rd December 2014 Agenda Overview of the pathology of cancer How specimens
Master Online Study Program @dvanced Oncology. Study part time team up internationally!
Master Online Study Program @dvanced Oncology Study part time team up internationally! Ulm University is developing an innovative international postgraduate study program @dvanced Oncology addressing clinical
Research Article Epidemiology, Treatment Patterns, and Outcomes of Metastatic Soft Tissue Sarcoma in a Community-Based Oncology Network
Sarcoma, Article ID 145764, 7 pages http://dx.doi.org/10.1155/2014/145764 Research Article Epidemiology, Treatment Patterns, and Outcomes of Metastatic Soft Tissue Sarcoma in a Community-Based Oncology
Cancer treatment. TOP EUROPEAN CANCER EXPERTISE The path to recovery
Cancer treatment TOP EUROPEAN CANCER EXPERTISE The path to recovery 0% LAND OF HIGH QUALITY HEALTHCARE Located in Finland, a land of high quality healthcare, Helsinki University Hospital is regarded as
Robert Bristow MD PhD FRCPC
Robert Bristow MD PhD FRCPC Clinician-Scientist and Professor, Radiation Oncology and Medical Biophysics, University of Toronto and Ontario Cancer Institute/ (UHN) Head, PMH-CFCRI Prostate Cancer Research
Diabetes. University Hospital
Danish Diabetes Academy Bone, Energy Metabolism and Diabetes - Integrated Physiology and Clinical Applications 3 & 4 Octob ber 2016 Sinatur Hotel Storebæ ælt, Østerøvej 121, Nyborg Organisation committee:
Cancer services children s CSCF v3.2
Cancer services children s CSCF v3.2 Module overview Please note: This module should be read in conjunction with the Fundamentals of the Framework (including glossary and acronym list), Children s Services
Departments of Nuclear Medicine, Surgery, and Endocrinology University of Ulm
4 th Würzburg Summer School of Thyroid Cancer Management A training course on basics, diagnosis and therapy of differentiated thyroid tumours under the auspices of the European Association of Nuclear Medicine
PROGRAMME NORDIC CONGRESS IN CLINICAL BIOCHEMISTRY
PROGRAMME 1. april 2016 2016 BASIC AND TRANSLATIONAL RESEARCH LAB ORGANISATION DISEASE ENTITIES BREAKS & SOCIAL EVENTS TUESDAY 14 JUNE 2016 14.00-16.00 Registration HCA 16.00-16.15 Opening ceremony Carl
The following information is only meant for people who have been diagnosed with advanced non-small cell
Important information for people with advanced non-small cell lung cancer The following information is only meant for people who have been diagnosed with advanced non-small cell lung cancer (NSCLC). NSCLC
POST-CONGRESS SATELLITE MEETINGS May 24 th, 2013. Cancer biomarkers 2013
20 th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine 45 th Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC) POST-CONGRESS SATELLITE
False positive PET in lymphoma
False positive PET in lymphoma Thomas Krause Introduction and conclusion 2 3 Introduction 4 FDG-PET in staging of lymphoma 34 studies with 2227 Patients CT FDG-PET Sensitivity 63 % 89 % (58%-100%) (63%-100%)
Scientific Committee. Andrés Cervantes (ESMO, GEICO) Antonio González (ESMO, GEICO) Andrés Poveda (ESMO, GEICO) Jan B. Vermorken (ESMO, GEICO)
Under the Auspices of Organized by 10th International Symposium Advanced Ovarian Cancer: Optimal Therapy. Update Valencia, Spain, 6th March 2015 Directors Andrés Poveda Fundación Instituto Valenciano de
The treatment and outcome of patients with soft tissue sarcomas and synchronous metastases
Sarcoma (2002) 6, 69 73 ORIGINAL ARTICLE The treatment and outcome of patients with soft tissue sarcomas and synchronous metastases JOHN M. KANE III, J. WILLIAM FINLEY, DEBORAH DRISCOLL, WILLIAM G. KRAYBILL
Lung Cancer Treatment Guidelines
Updated June 2014 Derived and updated by consensus of members of the Providence Thoracic Oncology Program with the aid of evidence-based National Comprehensive Cancer Network (NCCN) national guidelines,
Komorbide brystkræftpatienter kan de tåle behandling? Et registerstudie baseret på Danish Breast Cancer Cooperative Group
Komorbide brystkræftpatienter kan de tåle behandling? Et registerstudie baseret på Danish Breast Cancer Cooperative Group Lotte Holm Land MD, ph.d. Onkologisk Afd. R. OUH Kræft og komorbiditet - alle skal
2010 PhD, Department of Health Sciences, Institute of Nursing and Health Sciences, University of Oslo
CURRICULUM VITAE PhD, Physiotherapist, Specialized in Manual Therapy PERSONAL: Born: 1959 Private: Brattaasveien 2, 1415 Oppegaard, Norway. Tlf + 47 66991662, mobile +47 90607081 Work: Department Health
The importance of international. Collaborations in rare diseases
The importance of international collaborations in rare diseases the EURAMOS model Matthew Sydes Senior Medical Statistician MRC Clinical Trials Unit, London Overview Aim of presentation: 1 Introduce rationale
Management of Non-Small Cell Lung Cancer Guide for General Practitioners
Management of n-small Cell Lung Cancer Guide for General Practitioners Clinical Stage I Cancer only in one lobe of lung and
Osteosarcoma What are the differences between cancers in adults and children?
Osteosarcoma What are the differences between cancers in adults and children? The types of cancers that develop in children and teens are often different from the types that develop in adults. Childhood
Oncology. Objectives. Cancer Nomenclature. Cancer is a disease of the cell Cancer develops when certain cells begin to grow out of control
Oncology Objectives Describe the etiology and pathophysiological mechanisms of cancer Discuss medical and family history findings relevant to cancer Identify general signs and symptoms associated with
ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials)
ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials) 3 Integrated Trials Testing Targeted Therapy in Early Stage Lung Cancer Part of NCI s Precision Medicine Effort in
58th ANNUAL MEETING OF THE ITALIAN CANCER SOCIETY REVOLUTIONARY ROAD. VERONA SEPTEMBER 5-8 2016 Palazzo della GRAN GUARDIA. First Announcement
SEPTEMBER 5-8 2016 Palazzo della GRAN GUARDIA ABSTRACT DEADLINE May 2, 2016 First Announcement Scientific Coordinators Davide Melisi (Verona) Giampaolo Tortora (Verona) Local Scientific Committee Vincenzo
Azienda Ospedaliero-Universitaria di Bologna Policlinico S.Orsola-Malpighi - Bologna, Italy
Azienda Ospedaliero-Universitaria di Bologna Policlinico S.Orsola-Malpighi - Bologna, Italy General Information New breast cancer cases treated per year 284 Breast multidisciplinarity team members 14 Radiologists,
Effects of Herceptin on circulating tumor cells in HER2 positive early breast cancer
Effects of Herceptin on circulating tumor cells in HER2 positive early breast cancer J.-L. Zhang, Q. Yao, J.-H. Chen,Y. Wang, H. Wang, Q. Fan, R. Ling, J. Yi and L. Wang Xijing Hospital Vascular Endocrine
Keywords: osteosarcoma, metastasis of osteosarcoma, a second -line chemotherapy.
TREATMENT OF PATIENTS WITH METASTATIC OSTEOSARCOMA IN THE LUNGS P.A. Kovalchuk, A.G. Dedkov, A.V.Ganul, L.V.Bororov, I.B.Volkov, S.I. Boychuk, V.G.Tyhonov National cancer institute. Kiev Summary. The analysis
CARDIOVASCULAR PROBLEMS IN SURVIVORS OF CHILDHOOD CANCER AND THEIR SIBLINGS
Swiss Childhood Cancer Registry (SCCR) CARDIOVASCULAR PROBLEMS IN SURVIVORS OF CHILDHOOD CANCER AND THEIR SIBLINGS Julien Caccia, Corina S. Rueegg, Eva-Maria Hau, Nicolas X. von der Weid, Gisela Michel,
Groupe Hospitalier Avicenne-Jean Verdier, CHU de Paris-Seine-Saint-Denis - Bobigny, France
Groupe Hospitalier Avicenne-Jean Verdier, CHU de Paris-Seine-Saint-Denis - Bobigny, France General Information New breast cancer cases treated per year 280 Breast multidisciplinarity team members 11 Radiologists,
Public-Private Partnerships in early phase clinical research: Spurring access to innovative therapeutics
EPAAC WP8 Research Forum - 2 July, Sofitel Hotel Europe, Brussels Public-Private Partnerships in early phase clinical research: Spurring access to innovative therapeutics JY Blay, Past President EORTC
Report series: General cancer information
Fighting cancer with information Report series: General cancer information Eastern Cancer Registration and Information Centre ECRIC report series: General cancer information Cancer is a general term for
Advances in Lung Cancer: A Multidisciplinary Approach
Advances in Lung Cancer: A Multidisciplinary Approach Saturday, April 25, 2015 127 Public Square Cleveland, Ohio Learning Objectives About the Course This one-day course will provide a topical, clinically
.org. Osteochondroma. Solitary Osteochondroma
Osteochondroma Page ( 1 ) An osteochondroma is a benign (noncancerous) tumor that develops during childhood or adolescence. It is an abnormal growth that forms on the surface of a bone near the growth
Program Co-Chairmen: Dr. John Wagner, University of Minnesota Dr. Richard Champlin, M.D. Anderson Cancer Center
(last updated May 13, 2004) This is an activity offered by CBBS, a CMA accredited provider. Physicians attending this course may report up to 13.25 hours of Category 1 credits toward the California Medical
The PSA Controversy: Defining It, Discussing It, and Coping With It
The PSA Controversy: Defining It, Discussing It, and Coping With It 11 TH ANNUAL SYMPOSIUM ON MEN S HEALTH June 12, 2013 The PSA Controversy Defining It, Discussing It and Coping With It As of May 2012,
Adjuvant Therapy for Breast Cancer: Questions and Answers
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Adjuvant Therapy for Breast
Disease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? www.simpsonmillar.co.uk Telephone 0844 858 3200
GUIDE TO ASBESTOS LUNG CANCER What Is Asbestos Lung Cancer? Like tobacco smoking, exposure to asbestos can result in the development of lung cancer. Similarly, the risk of developing asbestos induced lung
2nd International Symposium on Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)
2nd International Symposium on Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) Wednesday Oct 7th, 2015 Congress Center (Hörsaal 1 3) Marien Hospital Herne Accreditation by the Medical Chamber
Breast cancer research and a changing treatment pathway
Breast cancer research and a changing treatment pathway Stuart McIntosh Clinical Senior Lecturer in Surgical Oncology, QUB Consultant Breast Surgeon, BCH What is the breast surgeon s role in 2016? Surgery
Osteosarcoma: treatment beyond surgery
Osteosarcoma: treatment beyond surgery Eric Chow, DVM DACVS Sue Downing, DVM DACVIM-Oncology Providing the best quality care and service for the patient, the client, and the referring veterinarian. Osteosarcoma
University of Bergen Haukeland University Hospital
University of Bergen Haukeland University Hospital Department of Clinical Science Department of Surgery Mini-Symposium QUALITY CONTROL IN THYROID SURGERY and 5. Surgical Course INTRAOPERATIVE NEUROMONITORING
AZ Sint Lucas - Brugge, Belgium
- Brugge, Belgium General Information New breast cancer cases treated per year 150 Breast multidisciplinarity team members 12 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists
The Brain and Spine CenTer
The Br ain and Spine Center Choosing the right treatment partner is important for patients facing tumors involving the brain, spine or skull base. The Brain and Spine Center at The University of Texas
- Pisa, Italy. Azienda Ospedaliero-Universitaria Di Pisa - Ospedale S. Chiara 1/6. General Information
- Pisa, Italy General Information New breast cancer cases treated per year 500 Breast multidisciplinarity team members 18 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists and
Complement in human disease, September 8th - 12th 2017
Complement in human disease, September 8th - 12th 2017 www.emchd2017.dk Copenhagen, Denmark venue Hotel Scandic Copenhagen september 8th - 12th 2017 Vester Søgade 6, 1601 COMPLEMENT IN HUMAN DISEASE 2017
Surgery. Wedge resection only part of the lung, not. not a lobe, is removed. Cancer Council NSW
The treatment you receive will depend on your lung cancer type, for example, whether you have a non-small cell lung cancer Adenocarcinoma or Squamous cell carcinoma, and if this is a sub-type with a mutation.
How To Treat A Uterine Sarcoma
EVERYONE S GUIDE FOR CANCER THERAPY Malin Dollinger, MD, Ernest H. Rosenbaum, MD, Margaret Tempero, MD, and Sean Mulvihill, MD 4 th Edition 2001 Uterus: Uterine Sarcomas Jeffrey L. Stern, MD Uterine sarcomas
DESMOPLASTIC SMALL ROUND CELL TUMOR: A RARE PATHOLOGY PUZZLE
DESMOPLASTIC SMALL ROUND CELL TUMOR: A RARE PATHOLOGY PUZZLE Ryan Granger University of Rhode Island Cytotechnology program May 2, 2015 ASCT Annual Meeting Nashville, Tennessee DESMOPLASTIC SMALL ROUND
Non Small Cell Lung Cancer: Scientific Discoveries and the Pursuit of Progress
Non Small Cell Lung Cancer: Scientific Discoveries and the Pursuit of Progress Lung Cancer Accounts for 14% of All New Cancer Diagnoses in the United States 1 Lung cancer is the second most common malignancy
Developments in Biomarker Identification and Validation for Lung Cancer
Developments in Biomarker Identification and Validation for Lung Cancer Alexandre Passioukov, MD, PhD Alexandre.Passioukov@eortc.be Contents Introduction Lung cancer pathogenesis NSCLC treatment options
FACULTY OF ALLIED HEALTH SCIENCES
FACULTY OF ALLIED HEALTH SCIENCES 102 Naresuan University FACULTY OF ALLIED HEALTH SCIENCES has focused on providing strong professional programs, including Medical established as one of the leading institutes
Lung Cancer and Pleural Mesothelioma: Cleveland Clinic Multidisciplinary Approaches to Care
Lung Cancer and Pleural Mesothelioma: Cleveland Clinic Multidisciplinary Approaches to Care Saturday, April 27, 2013 Cleveland Marriott Downtown at Key Center 127 Public Square Cleveland, Ohio Learning
www.nordiatrans.org Scientific Program Nordiatrans 41st Congress Oslo 8 9 March 2013 Theme: Early versus late
Scientific Program Nordiatrans 41st Congress Oslo 8 9 March 2013 Theme: Early versus late Friday 8 March 12.00 13.00 Registration & drop in lunch in the Exhibition hall 13.00 13.15 Opening Ceremony Madeleine
The Clinical database of DBCG
The Clinical database of DBCG (Danish Breast Cancer Cooperative Group) 1977-2008 Susanne Møller DBCG secretariate Copenhagen University Hospital 22. may 2008, SM 1 Number of patients with invasive breast
Pain in Dementia Future directions
Pain in Dementia Future directions Terminus Hall 24 th -25 th of April Preliminary programme TIME & PLACE The congress is set in Terminus Hall, Zander Kaasesgate 6, 5015 Bergen, 24 th -25 th of April,
Consortium led by Asbestos Diseases Research Institute (ADRI)
Translating Research into Better Outcomes for Patients with Asbestos-Related Disease and their Families Professor Nico van Zandwijk Consortium led by Asbestos Diseases Research Institute (ADRI) AUSTIN
Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma
The Use of Kinase Inhibitors: Translational Lab Results Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma Sheelu Varghese, Ph.D. H. Richard Alexander, M.D.
The annual meeting of DSKO 2014 preliminary program Hotel Nyborg Strand, the 27 th 29 th of March 2014
The annual meeting of DSKO 2014 preliminary program Hotel Nyborg Strand, the 27 th 29 th of March 2014 Thursday 27.3.2014 15.30 16.30 Registration and coffee Hypofractionation in radiotherapy for breast
YOUR LUNG CANCER PATHOLOGY REPORT
UNDERSTANDING YOUR LUNG CANCER PATHOLOGY REPORT 1-800-298-2436 LungCancerAlliance.org A GUIDE FOR THE PATIENT 1 CONTENTS What is a Pathology Report?...3 The Basics...4 Sections of a Pathology Report...7
Azienda Ospedale Annunziata Cosenza - Cosenza, Italy
- Cosenza, Italy General Information New breast cancer cases treated per year 180 Breast multidisciplinarity team members 9 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists and
A practical guide to understanding cancer. Understanding. Primary. bone. cancer
A practical guide to understanding cancer Understanding Primary bone cancer Contents 1 Contents About this booklet 2 1 The bones and primary bone cancer 5 2 Diagnosing primary bone cancer 19 3 Treating
Ewing Family of Tumors
Ewing Family of Tumors What is the Ewing family of tumors? Cancer starts when cells in the body begin to grow out of control. Cells in nearly any part of the body can become cancer, and can spread to other
Neoplasia gastrica cistica: GIST o leiomiosarcoma? Sebastiano Cacciaguerra U. O. Chirurgia Pediatrica Ospedale Garibaldi Catania
Neoplasia gastrica cistica: GIST o leiomiosarcoma? Sebastiano Cacciaguerra U. O. Chirurgia Pediatrica Ospedale Garibaldi Neoplasia gastrica cistica: GIST o leiomiosarcoma? Aims of presentation Atypical
3rd Annual Jefferson Lung Cancer Symposium
PAID REGISTER ONLINE NOW BY VISITING Jefferson.edu/CME Last Name First Name MI Title (Dr., Mr., Ms.) PERMIT NO. #117 SOUTHEASTERN, PA 19399 at Bluemle Life Sciences Building NON-PROFIT ORG U.S. POSTAGE
Specific Standards of Accreditation for Residency Programs in Pediatric Hematology/Oncology
Specific Standards of Accreditation for Residency Programs in Pediatric Hematology/Oncology INTRODUCTION 2009 A university wishing to have an accredited program in Pediatric Hematology/Oncology must also
Resolving Cancer Heterogeneity:
INTERNATIONAL SYMPOSIUM ON: Resolving Cancer Heterogeneity: The way to personalised medicine Palazzo della Gran Guardia Verona (Italy), June 30 th July 2 nd, 2016 PROGRAM Organized by: ARC-Net Centre for
Targeted Therapies in Lung Cancer
Targeted Therapies in Lung Cancer I Edited by: Simona Carnio Thoracic Oncology Division - St Luigi Hospital Orbassano (TO) - Italy Silvia Novello Department of Oncology - University of Torino - Italy Why
RICERCA FINALIZZATA+GIOVANI RICERCATORI MALATTIE RARE. Graduatoria e Finanziamento
Direzione Generale Ricerca Scientifica e Tecnologica RICERCA FINALIZZATA+GIOVANI RICERCATORI MALATTIE RARE Graduatoria e Finanziamento Ministero della Salute Direzione Generale Ricerca Scientifica e Tecnologica
Harmesh Naik, MD. Hope Cancer Clinic HOW DO I MANAGE STAGE 4 NSCLC IN 2012: STATE OF THE ART
Harmesh Naik, MD. Hope Cancer Clinic HOW DO I MANAGE STAGE 4 NSCLC IN 2012: STATE OF THE ART Goals Discuss treatment options for stage 4 lung cancer: New and old Discuss new developments in personalized
RESEARCH EDUCATE ADVOCATE. Just Diagnosed with Melanoma Now What?
RESEARCH EDUCATE ADVOCATE Just Diagnosed with Melanoma Now What? INTRODUCTION If you are reading this, you have undergone a biopsy (either of a skin lesion or a lymph node) or have had other tests in which
XXVIIII Annual Meeting Danish Society for Neuroscience (DSfN) Stem Cells in a Neurotranslational Perspective. May 11 12; 2015
XXVIIII Annual Meeting Danish Society for Neuroscience (DSfN) Stem Cells in a Neurotranslational Perspective May 11 12; 2015 Hotel Hesselet, Nyborg Symposium organizers Morten Blinkenberg, University of
Ductal carcinoma in situ (DCIS)
DIAGNOSIS: DCIS Ductal carcinoma in situ (DCIS) This factsheet gives information on an early form of breast cancer called ductal carcinoma in situ (DCIS). It explains what it is, how your breast is made
Santa Maria Annunziata Hospital / Azienda Sanitaria di Firenze
- Firenze, Italy General Information New breast cancer cases treated per year 350 Breast multidisciplinarity team members 12 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists and
Targeted Therapy What the Surgeon Needs to Know
Targeted Therapy What the Surgeon Needs to Know AATS Focus in Thoracic Surgery 2014 David R. Jones, M.D. Professor & Chief, Thoracic Surgery Memorial Sloan Kettering Cancer Center I have no disclosures
Update on Clinical Trials and Foundation Funded Grants
Update on Clinical Trials and Foundation Funded Grants Mary Hesdorffer, MS, APRN-BC Medical Liaison Meso Foundation www.curemeso.org Delivering the Diagnosis Delivering the Diagnosis Day 1 Taking control
Overvekt, mer enn bare overvekt
Overvekt, mer enn bare overvekt Kurs Overvekt i svangerskap og fødsel Overvekt/fedme i historisk perspektiv I løpet av1-2 generasjoner har det vært en økning i forekomsten av fedme som er historisk uovertroffen.